# Outrun Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/outrun-therapeutics

- Industry: Biotechnology
- Headquarters: Dundee, UK
- Website: www.outruntx.com
- Total disclosed funding: $10M
- Latest round: Seed (Apr 18, 2024)
- Investors on record: 2

## About

Established in 2019 and based in Scotland, UK, Outrun Therapeutics Limited develops and researches therapeutic rugs for protein and cancer treatment. In April 2024, the firm raised USD 10 million in Seed funding from investors M Ventures and MP Healthcare Venture Management. As of 2024, the company is headed by its CEO Dr. Carolyn Porter.

The company offers a platform with engineered protein sensor (EPS) technology that helps in the generation of E3 ligase inhibitors to stabilize proteins. The firm technology targets the E3 ligase that destabilizes a tumor suppressor protein in hard-to-treat solid tumors and helps in the treatment of cancer and other diseases.

The company plans to use the April 2024 funding to support its research and development initiatives.

## Funding rounds

- Seed, Apr 18, 2024, $10M — MP Healthcare Venture Management, M Ventures

## Investors

- MP Healthcare Venture Management (https://capitalatlas.ai/funds/mp-healthcare-venture-management) — Seed
- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Seed